TD Cowen analyst Ritu Baral maintained a Buy rating on Inventiva (IVA – Research Report) today. The company’s shares closed yesterday at ...

Milestone Pharmaceuticals (MIST – Research Report) received a Hold rating and price target from TD Cowen analyst Ritu Baral today. The ...

Jefferies equity analyst Andrew Tsai and Ritu Baral, a managing director and senior biotech analyst with TD Cowen, both observed. Elevidys is indicated for individuals at least four years old to ...

“We believe the urgent heart failure language could give Alnylam an advantage,” Ritu Baral, an analyst at TD Cowen, said, “especially for front-line use.” ...

TD Cowen analyst Ritu Baral provided insights from a key opinion leader (KOL) in orphan neuromuscular diseases, who spoke at an investor event hosted by the Muscular Dystrophy Association (MDA).

Gene therapy developer Sarepta Therapeutics (NASDAQ:SRPT) lost ~20% on Tuesday to reach a new 52-week low after the company disclosed the death of a patient treated with Elevidys, its FDA-approved ...

TD Cowen analyst Ritu Baral provided insights from a key opinion leader (KOL) in orphan neuromuscular diseases, who spoke at an investor event hosted by the Muscular Dystrophy Association (MDA).

Hostel operators seek help from the government and money from students to stay afloat. But the government hasn’t helped, and students themselves are under financial stress.

Experienced allrounder Ritu Moni has come back to the Bangladesh ODI squad for the women's World Cup qualifiers, to be held in Lahore next month. She last played an ODI against Ireland in December ...